Clinical subtypes and genetic heterogeneity: of lumping and splitting in Parkinson disease

被引:53
作者
von Coelln, Rainer [1 ]
Shulman, Lisa M. [1 ]
机构
[1] Univ Maryland, Sch Med, Dept Neurol, 110 S Paca St, Baltimore, MD 21201 USA
关键词
akinetic-rigid; heterogeneity; Parkinson disease; postural instability/gait difficulty; subtypes; tremor-dominant; GENOME-WIDE ASSOCIATION; ALPHA-SYNUCLEIN; LRRK2; G2019S; DIAGNOSTIC-CRITERIA; LEWY BODY; RISK; CLASSIFICATION; GAIT; AGE; NEUROPATHOLOGY;
D O I
10.1097/WCO.0000000000000384
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review Recent studies on clinical, genetic and pathological heterogeneity of Parkinson disease have renewed the old debate whether we should think of Parkinson disease as one disease with variations, or as a group of independent diseases that happen to present with similar phenotypes. Here, we provide an overview of where the debate is coming from, and how recent findings in clinical subtyping, genetics and clinicopathological correlation have shaped this controversy over the last few years. Recent findings New and innovative clinical diagnostic criteria for Parkinson disease have been proposed and await validation. Studies using functional imaging or wearable biosensors, as well as biomarker studies, provide new support for the validity of the traditional clinical subtypes of Parkinson disease (tremor-dominant versus akinetic-rigid or postural instability/gait difficulty). A recent cluster analysis (as unbiased data-driven approach to subtyping) included a wide spectrum of nonmotor variables, and showed correlation of the proposed subtypes with disease progression in a longitudinal analysis. New genetic factors contributing to Parkinson disease susceptibility continue to be identified, including rare mutations causing monogenetic disease, common variants with small effect size and risk factors (like mutations in the gene for glucocerebrosidase) that fall in between the two other categories. Recent studies show some limited correlation between genetic factors and clinical heterogeneity. Despite some variations in patterns of pathology, Lewy bodies are still the hallmark of Parkinson disease, including the vast majority of genetic subgroups. Summary Evidence of clinical, genetic and pathological heterogeneity of Parkinson disease continues to emerge, but clearly defined subtypes that hold up in more than one of these domains remain elusive. For research to identify such subtypes, splitting is likely the way forward; until then, for clinical practice, lumping remains the more pragmatic approach.
引用
收藏
页码:727 / 734
页数:8
相关论文
共 50 条
[41]   The heterogeneity of idiopathic Parkinson's disease [J].
Foltynie, T ;
Brayne, C ;
Barker, RA .
JOURNAL OF NEUROLOGY, 2002, 249 (02) :138-145
[42]   Genetic heterogeneity and subtypes of major depression [J].
Thuy-Dung Nguyen ;
Harder, Arvid ;
Xiong, Ying ;
Kowalec, Kaarina ;
Hagg, Sara ;
Cai, Na ;
Kuja-Halkola, Ralf ;
Dalman, Christina ;
Sullivan, Patrick F. ;
Lu, Yi .
MOLECULAR PSYCHIATRY, 2022, 27 (03) :1667-1675
[43]   Clinical Features of Parkinson's Disease: The Evolution of Critical Symptoms [J].
Varadi, Csaba .
BIOLOGY-BASEL, 2020, 9 (05)
[44]   Data-Driven Subtypes of Parkinson Disease Based on Dopamine Responsiveness [J].
Wang, Jian-Yong ;
Zeng, Guo-Ling ;
Tang, Rong-Ting ;
Luo, Hai-Tao ;
Song, Yu-Lian ;
Zhou, Yang-Yang ;
Huang, Jie-Fan ;
Zhu, Shi-Guo ;
Zhang, Dao-Lu ;
Liu, Dan-Ni ;
Liu, Rong-Pei ;
Huang, Shi-Shi ;
Yuan, Cheng-Xiang ;
Zhu, Jian-Hong ;
Zhang, Xiong .
CNS NEUROSCIENCE & THERAPEUTICS, 2025, 31 (04)
[45]   Subtypes of Parkinson's disease [J].
Ebersbach, Georg .
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2025, 93 (06) :243-254
[46]   CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study [J].
Kang, Ju-Hee ;
Mollenhauer, Brit ;
Coffey, Christopher S. ;
Toledo, Jon B. ;
Weintraub, Daniel ;
Galasko, Douglas R. ;
Irwin, David J. ;
Van Deerlin, Vivianna ;
Chen-Plotkin, Alice S. ;
Caspell-Garcia, Chelsea ;
Waligorska, Teresa ;
Taylor, Peggy ;
Shah, Nirali ;
Pan, Sarah ;
Zero, Pawel ;
Frasier, Mark ;
Marek, Kenneth ;
Kieburtz, Karl ;
Jennings, Danna ;
Tanner, Caroline M. ;
Simuni, Tanya ;
Singleton, Andrew ;
Toga, Arthur W. ;
Chowdhury, Sohini ;
Trojanowski, John Q. ;
Shaw, Leslie M. .
ACTA NEUROPATHOLOGICA, 2016, 131 (06) :935-949
[47]   Clinical heterogeneity in patients with early-stage Parkinson's disease: a cluster analysis [J].
Liu, Ping ;
Feng, Tao ;
Wang, Yong-jun ;
Zhang, Xuan ;
Chen, Biao .
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2011, 12 (09) :694-703
[48]   Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's disease [J].
Wijeyekoon, Ruwani S. ;
Kronenberg-Versteeg, Deborah ;
Scott, Kirsten M. ;
Hayat, Shaista ;
Kuan, Wei-Li ;
Evans, Jonathan R. ;
Breen, David P. ;
Cummins, Gemma ;
Jones, Joanne L. ;
Clatworthy, Menna R. ;
Floto, R. Andres ;
Barker, Roger A. ;
Williams-Gray, Caroline H. .
BRAIN BEHAVIOR AND IMMUNITY, 2020, 87 :473-488
[49]   Differential gait features across Parkinson's disease clinical subtypes [J].
Baudendistel, Sidney T. ;
Rawson, Kerri S. ;
Lessov-Schlaggar, Christina N. ;
Maiti, Baijayanta ;
Kotzbauer, Paul T. ;
Perlmutter, Joel S. ;
Earhart, Gammon M. ;
Campbell, Meghan C. .
CLINICAL BIOMECHANICS, 2025, 122
[50]   Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease [J].
Yilmaz, Rezzak ;
Strafella, Antonio P. ;
Bernard, Alice ;
Schulte, Claudia ;
van den Heuvel, Lieneke ;
Schneiderhan-Marra, Nicole ;
Knorpp, Thomas ;
Joos, Thomas O. ;
Leypoldt, Frank ;
Geritz, Johanna ;
Hansen, Clint ;
Heinzel, Sebastian ;
Apel, Anja ;
Gasser, Thomas ;
Lang, Anthony E. ;
Berg, Daniela ;
Maetzler, Walter ;
Marras, Connie .
FRONTIERS IN NEUROLOGY, 2018, 9